CD146 bound to LCK promotes T cell receptor signaling and antitumor immune responses in mice.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34491908.
- Also identified by DOI 10.1172/JCI148568 and PMC identifier 8553567.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Initiation of T cell receptor (TCR) signaling involves the activation of the tyrosine kinase LCK; however, it is currently unclear how LCK is recruited and activated. Here, we have identified the membrane protein CD146 as an essential member of the TCR network for LCK activation. CD146 deficiency in T cells substantially impaired thymocyte development and peripheral activation, both of which depend on TCR signaling. CD146 was found to directly interact with the SH3 domain of coreceptor-free LCK via its cytoplasmic domain. Interestingly, we found CD146 to be present in both monomeric and dimeric forms in T cells, with the dimerized form increasing after TCR ligation. Increased dimerized CD146 recruited LCK and promoted LCK autophosphorylation. In tumor models, CD146 deficiency dramatically impaired the antitumor response of T cells. Together, our data reveal an LCK activation mechanism for TCR initiation. We also underscore a rational intervention based on CD146 for tumor immunotherapy.
Medical subject headings
- Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
- Neoplasms, Experimental
- Receptors, Antigen, T-Cell
- Signal Transduction
- T-Lymphocytes